MedPath

Study of the impact of CYP2C19 gene polymorphism and H.pylori eradication in the treatment of ulcers PPI after endoscopic treatment(ESD:endoscopic submucosal dissection) of gastric neoplasm

Not Applicable
Conditions
early gastric cancer, gastric adenoma
Registration Number
JPRN-UMIN000015790
Lead Sponsor
Department of Gastroenterology,Seirei Hamamatsu General Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

1.H.pylor-negative patients 2.Patiants with surgical history of stomach 3.patients who are pregnant or nursing 4.patients who are diagnosed as unsuitable for this trial by investigatior

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath